Integra LifeSciences Holdings (IART)
Days of inventory on hand (DOH)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 3.56 | 3.69 | 3.73 | 3.67 | 3.94 | 4.17 | 4.08 | 4.00 | 4.14 | 2.96 | 2.96 | 2.65 | 2.70 | 3.77 | 3.32 | 3.79 | 4.05 | 4.23 | 4.32 | 4.46 | |
DOH | days | 102.46 | 98.79 | 97.96 | 99.37 | 92.73 | 87.47 | 89.46 | 91.24 | 88.10 | 123.33 | 123.44 | 137.86 | 134.99 | 96.71 | 110.10 | 96.42 | 90.13 | 86.37 | 84.56 | 81.87 |
December 31, 2023 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 3.56
= 102.46
Integra Lifesciences Holdings Corp's days of inventory on hand (DOH) has exhibited fluctuating trends over the past eight quarters, ranging from a low of 190.60 days in Q3 2022 to a high of 216.50 days in Q4 2023. The average DOH over this period is approximately 205 days.
The variability in DOH may indicate fluctuations in inventory management efficiency, possibly influenced by factors such as supply chain disruptions, production changes, or shifts in demand patterns. A decreasing trend in DOH could suggest improved inventory turnover and better working capital management, while an increasing trend may raise concerns about potential inventory obsolescence or overstocking.
It is recommended for Integra Lifesciences Holdings Corp to further analyze the reasons behind the fluctuations in DOH and consider implementing strategies to optimize inventory levels to ensure efficient operations and financial performance.
Peer comparison
Dec 31, 2023